Articles tagged "Liver transplantation"

2022 American Transplant Congress
Portal Vein Challenges in Pediatric Liver Transplantation: The Utility of Interposition Grafts as an Acceptable Management Strategy
K. Etesami¹, R. Hogen², J. Cervantes³, Y. Kwon⁴, S. Zielsdorf³, J. Emamaullee³, Y. Genyk³
¹Surgery, Children's Hospital Los Angeles, Los Angeles, CA, ²University of Southern California, West Hollywood, CA, ³University of Southern California, Los Angeles, CA, ⁴Hepatobiliary and Abdominal Transplant Surgery, University of Southern California, Los Angeles, CA
*Purpose: Portal vein (PV) anomalies and portal vein thrombosis (PVT) can present as challenging cases in the pediatric cohort, necessitating analysis and an algorithmic approach.*Methods:…
2022 American Transplant Congress
Pre-Transplant Evaluation of Patients Undergoing Combined Heart-Liver Transplantation and Correlation with Explant Pathology
A. Shingina¹, J. N. Menachem¹, S. Brown¹, I. A. Ziogas², W. K. Wu³, M. J. Izzy⁴, J. Liang¹, K. Washington¹, S. Alexopoulos⁵
¹Vanderbilt University Medical Center, Nashville, TN, ²Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, ³Thoracic Surgery; Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, ⁴GI and Hepatology, Vanderbilt University Medical Center, Nashville, TN, ⁵Vanderbilt Medical Center, Nashville, TN
*Purpose: Fontan-associated liver disease (FALD) is a well-described complication of Fontan physiology. More patients with failing Fontan are being evaluated for heart transplant and evidence-based…
2022 American Transplant Congress
Safety and Efficacy at 4 Years in Post-Liver Transplant Patients with Chronic Kidney Disease Receiving Tenofovir Alafenamide (TAF) for HBV Prophylaxis
E. Gane¹, B. George¹, D. Ray-Chaudhuri¹, T. Mules¹, C. D. Holt², H. Wang², V. Suri², A. Gaggar², A. Osinusi², J. Flaherty²
¹Auckland City Hospital and University of Auckland, Auckland, New Zealand, ²Gilead Sciences, Inc., Foster City, CA
*Purpose: Recommended antiviral prophylaxis to prevent recurrent HBV infection after liver transplantation includes tenofovir disoproxil fumarate (TDF). However, given risks of bone/renal toxicity associated with…
2022 American Transplant Congress
Liver Transplant Recipient History of Criminality: Impact on Clinical Outcomes
M. M. French¹, R. Mangus¹, R. Holmes¹, A. Krause¹, J. Sumner¹, C. Kubal¹, B. Ekser², P. Mihaylov³, A. Lutz⁴, J. Fridell⁵
¹Department of Surgery, Indiana University, Indianapolis, IN, ²Surgery, Indiana University - Transplant Surgery, Indianapolis, IN, ³Department of Surgery, Indiana Univ School of Medicine, Indianapolis, IN, ⁴Department of Surgery, Indiana University, Fishers, IN, ⁵Department of Surgery, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Health disparities are present in transplantation, just as in other areas of medicine. This is a retrospective review of liver transplant (LT) recipients to…
2022 American Transplant Congress
Retransplantation in a High-Volume Institution: Historical, Socioeconomic and Survival Trends
D. von Ahrens, O. Sulimani, M. Holzner, M. Akhtar, S. Florman, A. Arvelakis
The Mount Sinai Hospital, New York, NY
*Purpose: Retransplantation for liver allograft failure is a challenge within the field. The evolution of organ allocation policy from Child to MELD in 2002 and…
2022 American Transplant Congress
Assessment of Insulin Utilization for Early Post-Transplant Glycemic Control in Liver Transplant
L. F. Borges, K. Gutierrez, T. A. Sparkman, J. Banbury
UAB Hospital, Birmingham, AL
*Purpose: Transient hyperglycemia after liver transplant (LT) is common due to the use of high-dose steroids at the time of transplant, but some patients may…
2022 American Transplant Congress
Liver Transplant Outcomes with Persistent Post Transplant Alcohol Consumption
B. Evans¹, D. Patino², R. Sauls³, R. Shargo³, S. Mohammed³, M. Gosselin⁴, K. Robichaux³, A. Kumar⁵, J. Buggs¹
¹Transplant Surgery, Tampa General Hospital, Tampa, FL, ²Michigan State University College of Human Medicine, Lansing, MI, ³University of South Florida, Tampa, FL, ⁴University of Tampa, Tampa, FL, ⁵Morsani College of Medicine, University of South Florida, Tampa, FL
*Purpose: Although transplant centers educate patients on outcome risks from alcohol relapse, half of the alcoholic liver disease patients are thought to consume alcohol after…
2022 American Transplant Congress
Transplant Combined with Neoadjuvant Therapy Improves Survival for Patients with Liver-Limited, Locally Advanced Intrahepatic Cholangiocarcinoma: A SEER Database Analysis
G. G. Panayotova¹, M. Javle², S. Pentakota¹, F. Paterno¹, A. Amin¹, L. Brown¹, S. Simonishvili¹, Y. Qin¹, T. Ayorinde¹, G. Prakash¹, C. Conrad³, J. V. Guarrera¹, K. E. Lunsford¹
¹Rutgers New Jersey Medical School, Newark, NJ, ²University of Texas, MD Anderson Cancer Center, Houston, TX, ³St. Elizabeth's Medical Center, Boston, MA
*Purpose: Preliminary single-center data suggest multimodal therapy may improve outcomes for patients with intrahepatic cholangiocarcinoma (iCCA) undergoing liver transplant (LT), particularly in the setting of…
2022 American Transplant Congress
Impact of a Pharmacy-Led Post-Transplant Diabetes Mellitus Clinic in Solid Organ Transplant Recipients
H. Sweiss¹, R. Hall¹, M. Flores², S. Bhayana¹, R. Patel¹, C. Long²
¹University Health - University Hospital, San Antonio, TX, ²College of Pharmacy, University of Incarnate Word, San Antonio, TX
*Purpose: To evaluate the impact of a pharmacy-led post-transplant diabetes mellitus (DM) clinic.*Methods: This retrospective chart review from 08/01/20 to 6/30/21 evaluated adult kidney transplant…
2022 American Transplant Congress
Exploration of the Optimal pH in Hypothermic Machine Perfusion for Rat Liver Grafts Retrieved from Circulatory Death
S. Sakamoto¹, M. Fukai¹, K. Shibata¹, H. Bochimoto², N. Mohd Zin², N. Kawamura¹, T. Ishikawa¹, M. Fujiyoshi¹, T. Shimamura³, A. Taketomi¹
¹Department of Gastroenterological Surgery 1, Hokkaido University Graduate School, Sapporo, Japan, ²Department of Cell Physiology, The Jikei University School of Medicine, Tokyo, Japan, ³Division of Organ Transplantation, Hokkaido University Hospital, Sapporo, Japan
*Purpose: Although some investigators have reported favorable results of hypothermic machine perfusion (HMP) in liver transplantation, the efficacy to the hepatic graft retrieved from circulatory…